CENTOGENE’s Post

CENTOGENE's Chief Medical and Genomic Officer Peter Bauer recently sat down with Clinical Trials Arena to discuss the importance of genetic testing in Parkinson’s disease patient care. To hear more from Peter and how the latest data from our ROPAD Study demonstrates that identification of gene variants plays a key role in accelerating potential treatment options, visit: https://lnkd.in/e6AXgy5k #Parkinsons #Research #Science #Publication #Collaboration #Innovation #Genetics #ROPAD #CENTOGENE

ROPAD is a hugely innovative study. We need more of this!

To view or add a comment, sign in

Explore topics